Utilization of palliative therapy for metastatic melanoma in the United States - 12/10/21
, Jeremy S. Bordeaux, MD, MPH a, b, Rajiv I. Nijhawan, MD c| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Institutional Review Board approval was not required for the use of this publicly available, de-identified database. |
|
| This manuscript was presented at the virtual Society for Investigative Dermatology Annual Meeting, May 2020. Published abstract: Journal of Investigative Dermatology; SID Conference Proceedings. 140(7): LB929. DOI: 10.1016/j.jid.2020.05.021. |
|
| Reprints not available from the authors. |
Vol 85 - N° 5
P. 1342-1345 - novembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
